Skip to content
Open access

Cytomegalovirus Modulation of CD8 T Cell Phenotype and Function in People Living with HIV-1

Aug 2026 · Journal of the Pediatric Infectious Diseases Society · Vol 15, pp. S21-S22 · 0 citations

TL;DR

A subset of CMV-positive individuals with a marked expansion of CMV-specific CD8 T cells associated with markers of poor HIV-1 control are observed, which suggests an inappropriately elderly immune tone phenotype with HIV-1-CMV co-infection.

Abstract

Both human immunodeficiency virus 1 (HIV-1) and cytomegalovirus (CMV) cause lifelong infections that cannot be cured by antiviral chemotherapy due to persistent latent viral reservoirs. CMV frequently co-infects people living with HIV-1 (PLWH). There is mounting evidence that chronic CMV alters immune responses to various subsequent infections, and that large clonal expansions of CMV-specific CD8 T cells in elderly persons are markers of immune senescence. We propose that CMV co-infection may contribute to dysregulated viral control in PLWH. Peripheral blood samples and clinical data were prospectively collected over 18 months from 87 PLWH and 47 individuals without HIV-1 infection. All subjects were males (ages 18-28) receiving anti-retroviral therapy (ART) as treatment or pre-exposure prophylaxis (PrEP). HIV-1 viral titers, HIV-1 antigen/antibody screens, and CMV IgM and IgG ELISAs were monitored throughout the study. T cell surface protein expression and HIV-1 and CMV-specific pentamer staining were assessed using flow cytometry on longitudinal samples from 65 individuals. Viral-specific CD8 T cells isolated from 17 PLWH using barcoded antigen dextramer staining were profiled by gene expression and T cell receptor repertoire sequencing using single-cell RNA sequencing. Individuals were categorized as “normal” or “high” CMV responders based on their frequency of CMV-specific CD8 T cells. Of 126 specimens evaluated via flow cytometry, 112 had normal CMV-specific CD8 T cell responses (0-3.5% of CD8 T cells per pentamer used), and 14 had high responses (4.2-18%). All high responders (6/65, 9.2%) had chronic HIV-1 infection, their HIV-1 viral loads were increased, and CD4/CD8 T cell ratios were decreased compared to PLWH with normal CMV responses. CMV responder status was associated with changes in the size and phenotypes of both pan-CD8 and HIV-1-specific CD8 T cells. High responders’ expansions of CMV-specific CD8 T cells appeared largely clonal without affecting overall diversity of the CMV response. HIV-specific CD8 T cells from a high responder exhibited a heightened cytotoxicity transcriptional profile when compared to those from a normal responder. In our cohort of young PLWH, we observed a subset of CMV-positive individuals with a marked expansion of CMV-specific CD8 T cells associated with markers of poor HIV-1 control, as well as changes in activation and transcriptional profiles of both total and HIV-1-specific CD8 T cells. This suggests an inappropriately elderly immune tone phenotype with HIV-1-CMV co-infection. Further work is needed to assess impacts to the HIV-1 reservoir, viral control, and non-AIDS-associated morbidity in PLWH on ART.

Read PDF

Similar papers

Sep 2026

Functional T Cell Responses Are Associated With Prolonged HIV Control After Treatment Interruption.

BACKGROUND CD8+ T cell responses are thought to be critical for spontaneous control of human immunodeficiency virus (HIV) but findings supporting their role in post-intervention control have been mixed. We hypothesized that HIV-specific T cell proliferation, interferon-γ (IFN-γ) and granzyme B response prior to analyti...

Anders B. Andersen, A. K. Juhl, J. Gunst et al. · 0 citations
Sep 2026

Sex-modulated associations between cytomegalovirus cell-associated DNA and cognition in people with HIV on ART.

BACKGROUND People with HIV (PWH) remain at risk for cognitive impairment, despite effective antiretroviral therapy (ART), a phenomenon linked to chronic immune activation and inflammation. Cytomegalovirus (CMV) has been implicated in HIV-associated neurocognitive impairment, but most studies rely on serologic measures...

Alfonso Cabello-Úbeda, Patricia K. Riggs, G. Honerkamp-Smith et al. · 0 citations
Open access Aug 2026

The immunophenotype and proviral landscape of HIV-infected CD4 T cells during antiretroviral therapy

Significance The persistence of HIV in CD4+ T cells during antiretroviral therapy (ART) remains a barrier to cure. To study this reservoir, we developed an open-source DAb-seq platform that sequences proviral DNA and surface epitopes in single cells and profiled ~527,000 CD4 T cells from individuals on ART. HIV-infecte...

C. Delley, Sakshi Shah, Kevin M. Joslin et al. · 0 citations
Review Open access Aug 2026

Host genetic determinants of HTLV-1 infection outcomes

Human T-cell lymphotropic virus type 1 (HTLV-1) is a persistent human retrovirus associated with severe outcomes, most notably adult T-cell leukemia/lymphoma (ATLL) and HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP). Despite lifelong infection, only a minority of carriers develop clinical disease,...

Mohammad Mehdi Akbarin, Zahra Farjami, H. R. Álvarez · 0 citations
Open access Aug 2026

Phenotypic characterization of mucosal-associated invariant T cells in visceral leishmaniasis and HIV co-infection

Introduction Mucosal-associated invariant T (MAIT) cells are unconventional T lymphocytes with innate-like antimicrobial responsiveness. Despite their recognized role in bacterial and viral infections, their involvement in protozoal diseases, particularly visceral leishmaniasis (VL) and HIV co-infection, remains poorly...

Victória Hellena Silva Pereira, Gustavo Augusto Fonseca Nogueira, L. Borges-Fernandes et al. · 0 citations
Open access Sep 2026

Immunosenescence and immune dysfunction in treated and untreated HIV-infected individuals

To better understand the immune alterations resulting from HIV infection and antiretroviral therapy, we analysed various markers of immunosenescence and immune dysregulation in HIV-1-infected individuals on prolonged combination antiretroviral therapy (cART) (HIV+ART+), treatment-naïve HIV+ individuals (HIV+ART-),...

A. Unissa, A. Madheswaran, A. Inbanathan et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.